Cargando…

Transcriptional regulation of endothelial dysfunction in atherosclerosis: an epigenetic perspective

Atherosclerosis is a progressive human pathology that encompasses several stages of development. Endothelial dysfunction represents an early sign of lesion within the vasculature. A number of risk factors for atherosclerosis, including hyperlipidemia, diabetes, and hypertension, target the vascular...

Descripción completa

Detalles Bibliográficos
Autor principal: Xu, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Department of Journal of Biomedical Research 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3904174/
https://www.ncbi.nlm.nih.gov/pubmed/24474963
http://dx.doi.org/10.7555/JBR.27.20130055
_version_ 1782301193803923456
author Xu, Yong
author_facet Xu, Yong
author_sort Xu, Yong
collection PubMed
description Atherosclerosis is a progressive human pathology that encompasses several stages of development. Endothelial dysfunction represents an early sign of lesion within the vasculature. A number of risk factors for atherosclerosis, including hyperlipidemia, diabetes, and hypertension, target the vascular endothelium by re-programming its transcriptome. These profound alterations taking place on the chromatin rely on the interplay between sequence specific transcription factors and the epigenetic machinery. The epigenetic machinery, in turn, tailor individual transcription events key to atherogenesis to intrinsic and extrinsic insults dictating the development of atherosclerotic lesions. This review summarizes our current understanding of the involvement of the epigenetic machinery in endothelial injury during atherogenesis.
format Online
Article
Text
id pubmed-3904174
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Editorial Department of Journal of Biomedical Research
record_format MEDLINE/PubMed
spelling pubmed-39041742014-01-28 Transcriptional regulation of endothelial dysfunction in atherosclerosis: an epigenetic perspective Xu, Yong J Biomed Res Invited Review Atherosclerosis is a progressive human pathology that encompasses several stages of development. Endothelial dysfunction represents an early sign of lesion within the vasculature. A number of risk factors for atherosclerosis, including hyperlipidemia, diabetes, and hypertension, target the vascular endothelium by re-programming its transcriptome. These profound alterations taking place on the chromatin rely on the interplay between sequence specific transcription factors and the epigenetic machinery. The epigenetic machinery, in turn, tailor individual transcription events key to atherogenesis to intrinsic and extrinsic insults dictating the development of atherosclerotic lesions. This review summarizes our current understanding of the involvement of the epigenetic machinery in endothelial injury during atherogenesis. Editorial Department of Journal of Biomedical Research 2014-01 2013-06-03 /pmc/articles/PMC3904174/ /pubmed/24474963 http://dx.doi.org/10.7555/JBR.27.20130055 Text en © 2014 by the Journal of Biomedical Research. All rights reserved.
spellingShingle Invited Review
Xu, Yong
Transcriptional regulation of endothelial dysfunction in atherosclerosis: an epigenetic perspective
title Transcriptional regulation of endothelial dysfunction in atherosclerosis: an epigenetic perspective
title_full Transcriptional regulation of endothelial dysfunction in atherosclerosis: an epigenetic perspective
title_fullStr Transcriptional regulation of endothelial dysfunction in atherosclerosis: an epigenetic perspective
title_full_unstemmed Transcriptional regulation of endothelial dysfunction in atherosclerosis: an epigenetic perspective
title_short Transcriptional regulation of endothelial dysfunction in atherosclerosis: an epigenetic perspective
title_sort transcriptional regulation of endothelial dysfunction in atherosclerosis: an epigenetic perspective
topic Invited Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3904174/
https://www.ncbi.nlm.nih.gov/pubmed/24474963
http://dx.doi.org/10.7555/JBR.27.20130055
work_keys_str_mv AT xuyong transcriptionalregulationofendothelialdysfunctioninatherosclerosisanepigeneticperspective